| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 66, 173-180, Copyright © 1988 by Endocrine Society
ARTICLES |
EM Rutanen, F Pekonen and T Makinen
Minerva Institute for Medical Research, Helsinki, Finland.
The human secretory phase endometrium synthesizes and secrets a 34K insulin-like growth factor (IGF)-binding protein designated placental protein 12. We now report that membrane preparations of human endometrium possess IGF receptors that complete with the soluble binding protein for binding to IGF-I. Multiplication-stimulating activity and insulin were 1% and 0.1% as potent as recombinant (Thr59)IGF-I in inhibiting the binding of [125I](Thr59)IGF-I to endometrial membranes. Scatchard plots for the IGF-I binding data were curvilinear, and the apparent affinities [Ka = 1.4 +/- 0.2 ( +/- SEM) X 10(9) M-1] for (Thr59)IGF-I (high affinity site) did not change during the menstrual cycle. Affinity cross-linking of [125I](Thr59)IGF-I to endometrial membranes revealed two major bands with mol wt of 130K and 260K on sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. The 130K band is consistent with the alpha-subunit of the type I IGF receptor. The 260K band is either the type II IGF receptor or represents cross-linking (dimer) of two alpha-subunits of the type I receptor. A less intense band at about 40K was also seen in all membrane preparations. It comigrated with the cross-linked purified 34K binding protein. The band was more intensely labeled when the tracer was cross-linked to proteins in the cytosol fractions of late secretory phase endometria. By specific RIA, the 34K binding protein was detected in the cytosol of late secretory phase endometria only. Newly synthesized binding protein, which contaminated membrane preparations, caused an apparent increase in the binding of (Thr59)IGF- I to the membranes prepared from late secretory phase endometria when studied by competitive binding assay. In contrast, purified binding protein prevented the binding of [125I](Thr59)IGF-I to membrane receptors, as confirmed by affinity cross-linking. These results suggest that the 34K IGF-binding protein, secreted by the human endometrium in a cyclic fashion, has a significant role in inhibiting the receptor binding and, thus, the possible biological action of IGF-I in the endometrium in an autocrine/paracrine manner.
This article has been cited by other articles:
![]() |
B. J. Fan, D. Y. Wang, C. C. Y. Tham, D. S. C. Lam, and C. P. Pang Gene Expression Profiles of Human Trabecular Meshwork Cells Induced by Triamcinolone and Dexamethasone Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1886 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ihnatovych, W. Hu, J. L. Martin, A. T. Fazleabas, P. de Lanerolle, and Z. Strakova Increased Phosphorylation of Myosin Light Chain Prevents in Vitro Decidualization Endocrinology, July 1, 2007; 148(7): 3176 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Slomiany and S. A. Rosenzweig Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19 Am J Physiol Cell Physiol, September 1, 2004; 287(3): C746 - C753. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Slomiany and S. A. Rosenzweig IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407 Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Strakova, M. Szmidt, S. Srisuparp, and A. T. Fazleabas Inhibition of Matrix Metalloproteinases Prevents the Synthesis of Insulin-Like Growth Factor Binding Protein-1 during Decidualization in the Baboon Endocrinology, December 1, 2003; 144(12): 5339 - 5346. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishibashi, Y. Takagi, K. Mori, S. Naruse, H. Nishino, B. Y. J. T. Yue, and S. Kinoshita cDNA Microarray Analysis of Gene Expression Changes Induced by Dexamethasone in Cultured Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3691 - 3697. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Maures and C. Duan Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1 Endocrinology, July 1, 2002; 143(7): 2722 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kajantie, L. Dunkel, E.-M. Rutanen, M. Seppala, R. Koistinen, A. Sarnesto, and S. Andersson IGF-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1, and Postnatal Growth in Very Low Birth Weight Infants J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2171 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Strakova, S. Srisuparp, and A. T. Fazleabas Interleukin-1{beta} Induces the Expression of Insulin-Like Growth Factor Binding Protein-1 during Decidualization in the Primate Endocrinology, December 1, 2000; 141(12): 4664 - 4670. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Hytinantti, E-M Rutanen, M Turpeinen, R Sorva, and S Andersson Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 17F - 20. [Abstract] [Full Text] |
||||
![]() |
J. Gogusev, J. B. de Joliniere, L. Telvi, M. Doussau, A. Stojkoski, and M. Levradon Cellular and Genetic Constitution of Human Endometriosis Tissues Reproductive Sciences, March 1, 2000; 7(2): 79 - 87. [Abstract] [PDF] |
||||
![]() |
J. O. Nygren, A. Thorell, M. Soop, S. Efendic, K. Brismar, F. Karpe, K. S. Nair, and O. Ljungqvist Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E140 - E148. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Martina, E. Kim, U. Chitkara, N. C. Wathen, T. Chard, and L. C. Giudice Gestational Age-Dependent Expression of Insulin-Like Growth Factor-Binding Protein-1 (IGFBP-1) Phosphoisoforms in Human Extraembryonic Cavities, Maternal Serum, and Decidua Suggests Decidua as the Primary Source of IGFBP-1 in these Fluids during Early Pregnancy J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1894 - 1898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |